Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8238492 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 6 Pages |
Abstract
Patients treated with surgery and radiotherapy or chemoradiation for rectal cancer had a low risk of locoregional recurrence, with the majority of recurrences occurring within the radiation field. Because 78% of in-field recurrences occur in the low pelvic and presacral regions, consideration should be given to including the low pelvic and presacral regions in the radiotherapy boost field, especially in patients at high risk of recurrence.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Tse-Kuan M.D., Ph.D., Priya R. M.D., Christopher H. M.D., Revathy B. M.D., John M. M.D., Miguel A. M.D., Barry W. M.D., George J. M.D., Cathy M.D., Robert A. M.D., Nora A. M.D., M.P.S.A., Marc E. M.D., Sunil M.D., Prajnan M.D., M.S., M.P.H.,